IRIS
BAUCKNEHT, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.277
AS - Asia 94
SA - Sud America 5
NA - Nord America 4
Totale 14.380
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.277
CN - Cina 75
SG - Singapore 18
BR - Brasile 5
US - Stati Uniti d'America 4
JP - Giappone 1
Totale 14.380
Salva come PNG Salva come JPEG
Città #
Genoa 6.542
Genova 4.619
Vado Ligure 1.600
Rapallo 1.470
Bordighera 40
Beijing 31
Singapore 11
Ashburn 2
Milan 2
Rome 2
Boydton 1
Cuiabá 1
Itabaiana 1
Nanjing 1
Nova Petrópolis 1
Suzano 1
São Paulo 1
Tokyo 1
Wenzhou 1
Totale 14.328
Salva come PNG Salva come JPEG
Nome #
18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: Inverse correlation between calcification density and mineral metabolic activity 228
The vulnerable coronary plaque: update on imaging technologies. 198
A Mathematical Model for the Vessel Recruitment in Coronary Microcirculation In the Absence of Active Autoregulation 172
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 172
Amyloid positron emission tomography and cognitive reserve. 170
Cardiovascular effects of antimuscarinic agents in overactive bladder 168
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 166
Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by Koivuniemi et al. 165
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 164
Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CT 163
Spinocerebellar ataxia 17: full phenotype in a 41 CAG/CAA repeats carrier. 159
Assessment of skeletal tumor load in metastasized castration-resistant prostate cancer patients: A review of available methods and an overview on future perspectives 157
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 156
A new frontier for amyloid PET imaging: multiple sclerosis 156
Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity. 153
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 153
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 152
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 152
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational18F-FDG PET/CT observation 150
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 150
FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study 149
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells 147
Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress 144
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 140
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 140
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence 136
A kinetics-based approach to amyloid PET semi-quantification 135
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 135
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 134
Early identification of MCI converting to AD: a FDG PET study 133
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 131
A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility 131
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 129
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 128
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 128
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: A Possible Role for RANK/RANKL Pathway 127
Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles 126
18f-fluorodeoxyglucose positron emission tomography tracks the heterogeneous brain susceptibility to the hyperglycemia-related redox stress 125
Obligatory role of endoplasmic reticulum in brain FDG uptake 124
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 122
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) 121
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 121
New tracers and new perspectives for molecular imaging in Lewy body diseases 120
Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images 119
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 117
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223 116
Metabolic patterns across core features in dementia with lewy bodies 114
Diagnostic value of ischemia severity at myocardial perfusion imaging in elderly persons with suspected coronary disease 113
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 113
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 113
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia 112
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder 112
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 112
18F-Fluorodeoxyglucose Imaging of Inflammation: Ready to Represent a Standard in Diagnosing Endocarditis? 110
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab 110
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 105
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography? 104
Metabolic correlates of dopaminergic loss in dementia with lewy bodies 102
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 101
Neuroimaging Findings in Mild Cognitive Impairment 100
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 100
Amyloid PET imaging: Standardization and integration with other Alzheimer's disease biomarkers 98
18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at? 98
Probing the Role of a Regional Quantitative Assessment of Amyloid PET 97
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 96
18F-FDG-PET correlates of aging and disease course in ALS as revealed by distinct PVC approaches 95
Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection 95
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer 95
Development of new theranostic probes targeting PSMA: computational strategies to explore ligand-target interactions 94
Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study 93
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 91
Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma 89
Divergent Oxidative Stress in Normal Tissues and Inflammatory Cells in Hodgkin and Non-Hodgkin Lymphoma 89
Baseline 18F-Fluoride PET-derived parameters predict modification of toxicity-and response-related blood biomarkers in prostate cancer patients treated with 223Ra-Dichloride: preliminary results 89
Myocardial metabolic response predicts chemotherapy curative potential on hodgkin lymphoma: A proof-of-concept study 89
Mitochondrial Generated Redox Stress Differently Affects the Endoplasmic Reticulum of Circulating Lymphocytes and Monocytes in Treatment‐Naïve Hodgkin’s Lymphoma 88
REPLY: Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders? 87
The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes 87
Prognostic power of the human psoas muscles FDG metabolism in amyotrophic lateral sclerosis 85
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 85
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET 83
The Role of Endoplasmic Reticulum in the Differential Endurance against Redox Stress in Cortical and Spinal Astrocytes from the Newborn SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis 82
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 81
2-[18 F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study 81
Doxorubicin effect on myocardial metabolism: a translational 18F-FDG PET/CT approach 80
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 80
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 79
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) 79
Non-invasive measurement of coronary flow reserve: uniqueness of radionuclide methods and alternative techniques 77
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management 76
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 75
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 74
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 74
The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (Nsclc) in radiological progression during treatment with nivolumab 72
Brain FDG-PET findings in chimeric antigen receptor T-cell therapy neurotoxicity for diffuse large B-cell lymphoma 71
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 71
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica 70
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study 69
Sex differences in neuroimaging biomarkers in healthy subjects and dementia 68
Concomitant prostate cancer and hodgkin lymphoma: A differential diagnosis guided by a combined 68ga-psma-11 and 18f-fdg pet/ct approach 63
Totale 11.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.321
article - articoli 60.055
book - libri 0
conference - conferenze 1.238
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.765
Totale 126.379
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021897 0 0 0 126 94 115 118 91 89 111 80 73
2021/20221.276 48 37 68 126 60 110 41 225 114 169 81 197
2022/20231.751 117 190 31 161 242 226 32 146 234 92 249 31
2023/20241.389 59 139 38 196 91 255 109 83 64 56 85 214
2024/20254.416 179 291 153 283 444 432 377 871 222 223 472 469
2025/20262.392 1.105 293 480 514 0 0 0 0 0 0 0 0
Totale 14.855